Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Discover when it’s advisable to keep cash instead of opting for bank deposits. This information will help you manage your money wisely.
23,560 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Rumors swirl about a SpaceX IPO and what it means for space equities. This guide breaks down the potential good, bad,...
When a high-profile buyout falls short of expectations, stocks swing and traders scramble for context. This deep dive...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
Wells Fargo and Jefferies boosted ONEOK on Wednesday, citing a structural shift in energy demand tied to Iran-related...
Marvell Technology stock today is moving on a mix of data-center demand, strategic bets, and fresh analyst optimism. ...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
A new projection shows how a $400,000 investment in SCHD could generate roughly $50,000 of annual dividends over 15 y...
CoreWeave has rallied this year as AI infrastructure demand heats up. This article breaks down why the stock around t...
Supermicro sits at the intersection of exploding AI demand and serious credibility concerns. This article breaks down...
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...
Visa reports solid growth as it guards a $700 billion payments empire against threats from real-time rails and crypto...